Diabetes Self-Management Blog

When people who have Type 2 are diagnosed with cancer, their focus on diabetes is often moved to the back burner while they concentrate on cancer treatment. But ignoring blood glucose levels can create a dangerous set of circumstances for both conditions, according to new research from Northwestern University.

In addition to the short-term risks of high blood glucose levels, such as blurry vision and fatigue, and long-term risks, such as neuropathy (nerve damage) and retinopathy (eye damage), uncontrolled diabetes also impairs the immune system’s ability to fight off cancer. People with diabetes have a higher incidence of several types of cancer, including liver, pancreatic, colon, breast, bladder, and endometrial cancers.

To determine the effects of diabetes education on health in people with diabetes and cancer, researchers looked at five years of health records from 222,000 people. According to the records, approximately 3.8% of people without cancer and 3.5% of those with cancer received diabetes education two times a week over a period of four to six weeks.

They found that 65.2% of those with diabetes and cancer who had received diabetes education had their A1C (a measure of blood glucose control over the previous 2–3 months) level checked at least twice and 88% had their A1C level checked at least once over the course of three years. In people with cancer who had not received diabetes education, only 48% of people had their A1C level checked at least twice and 78% had it checked at least once over the course of three years. According to recommendations from the American Diabetes Association, A1C should be checked at least once every three months.

Additionally, among those who received diabetes education, there were 416 emergency room visits and 658 hospital admissions compared to 463 emergency room visits and 883 hospital admissions among those who did not receive the education.

“People with diabetes hear cancer and they think that it is a death sentence, so who cares about diabetes at this point?” noted senior study author June McKoy, MD, director of geriatric oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “But if they’re not careful, it’s the diabetes that will take them out of this world, not the cancer. That’s why this education is so critical when cancer comes on board. Patients must take care of both illnesses.”

For more information, read the article “Diabetics With Cancer Dangerously Ignore Blood Sugar” or see the study’s abstract in journal Population Health Management. To learn more about managing diabetes while undergoing cancer treatments, listen to this podcast or read these Q&As from the University of Texas MD Anderson Cancer Center. And to connect with others who are dealing with cancer, visit the Web site cancerforums.net.


  1. it is the same with chronic kidney disease..you gotta do the kidney diet to save yourself and you gotta watch the diabetes and you have to have great doctors who all coordinate with one another

    Posted by marylittle |

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.

Diabetes Research
Pistachios Offer Protection for People With Diabetes (08/29/14)
New Approach for Neuropathy Pain? (08/18/14)
Metformin Study Currently Recruiting (08/19/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)

Diabetes News
Pistachios Offer Protection for People With Diabetes (08/29/14)
New Approach for Neuropathy Pain? (08/18/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)
Shift Work Tied to Increased Type 2 Diabetes Risk (07/31/14)

Diane Fennell
Pistachios Offer Protection for People With Diabetes (08/29/14)
New Approach for Neuropathy Pain? (08/18/14)
New Metformin Combo Drug Approved for Type 2 Diabetes (08/13/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)



Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.